Back to Peter Attia MD

406 ‒ Migraine, cluster headache, and tension headache: symptoms, causes, prevention, and treatment

Peter Attia MDAugust 31, 20262h 9m
Topics47
Introduction to Headache Medicine0:00Diagnostic Challenges in Headache Medicine4:31Tension-Type Headache10:30Migraine Diagnostic Criteria11:30Allodynia and Migraine Phases13:31Aura in Migraine16:30Migraine Prevalence and Impact20:30Spectrum of Migraine Severity22:00Training Shortage in Headache Medicine24:31Genetic and Hormonal Factors in Migraine Susceptibility25:56Estrogen Decline and Migraine Mechanism28:31Estrogen Supplementation Studies31:01Genetic Inheritance Patterns32:31Migraine Triggers and Weather Patterns35:02Headache Diary Importance37:01Menopause and Migraine Transitions38:30Migraine Phases and Full Impact Assessment41:02Tension-Type Headache Characteristics45:31Cluster Headache: Clinical Presentation47:32Cluster Headache Genetics and Misdiagnosis51:02Cluster Headache Diagnosis and Primary Care Navigation52:20Treatment Approaches for Cluster Headache54:31Migraine Risk Factors and Modifiable Interventions56:31Additional Migraine Risk Factors1:01:02Individualized Lifestyle Modification Approach1:04:30Headache Diaries and Clinical Decision-Making1:08:31Goals and Indications for Preventive Therapy1:12:01Cluster Headache and Tension Headache Prevention1:16:01Beta Blockers in Headache Prevention1:17:01Beta Blockers for Migraine Prevention1:17:15Antidepressants in Migraine Treatment1:18:00Anti-Epileptic Medications for Migraine1:20:30CGRP Monoclonal Antibodies - Background and Pathophysiology1:23:31CGRP Antagonists - Monoclonal Antibodies1:30:00Gepants - Oral CGRP Antagonists1:36:04Calcium Channel Blockers1:39:02Botox for Chronic Migraine1:40:30Insurance Requirements for Botox1:43:12Acute Rescue Medications1:43:32Migraine-Specific Acute Treatments1:45:30Treatment Efficacy Metrics1:51:31Neuromodulation Devices1:52:30Cannabis and Cannabinoids1:57:02Clinical Recommendations1:59:01Secondary Headache Warning Signs2:01:32CSF Leak Considerations2:06:30Clinical Practice Information2:07:00
In a Nutshell

Headache disorders lack biomarkers and rely on clinical criteria: tension-type headache is bilateral, non-throbbing, and mild; migraine requires 4-72 hour attacks with nausea or both photophobia/phonophobia plus two of unilateral, throbbing, movement-aggravated, moderate-severe pain; cluster headache is unilateral, periorbital, 15 min-3 hr, with autonomic features and marked restlessness. Only ~50 new headache specialists finish training yearly despite migraine affecting 12% of people; preventive therapy (CGRP mAbs, topiramate, propranolol, Botox for chronic migraine) is indicated once attacks become frequent or disabling, yet only 16-17% of eligible patients receive it. Acute treatment favors migraine-specific triptans or gepants over opioids/barbiturates, which risk medication-overuse headache; lifestyle regularity, headache diaries, and addressing comorbidities (sleep apnea, obesity, mood disorders) are essential to prevent chronification.

AI-Generated Notes

These notes were generated by AI and may contain inaccuracies.

Brian Grosberg is a neurologist specializing in headache medicine. Headache is one of the most common neurologic symptoms, with nearly every person experiencing a headache at some point. Medical education provides minimal headache training, with medical students and neurology residents receiving only a few hours of lectures across their entire training.

Grosberg entered the field by accident during his first month of neurology residency when caring for a litigator disabled for six weeks by a prolonged migraine. His future mentor recognized his detailed history-taking ability and offered additional training. Grosberg pursued headache medicine training on his own time during residency, working with his mentor after long hospital shifts, then completed formal fellowship training.

No biomarkers exist for headache diagnosis. Neither CT scans nor MRIs reveal the source of pain. The International Classification of Headache Disorders serves as the diagnostic reference and categorizes headaches as primary or secondary.

Primary headaches are syndromes in themselves, not attributable to another condition. The most common include migraine, tension-type headache, and cluster headache.

Secondary headaches are attributable to an underlying condition. Examples include medication overuse headache from frequent acute pain medication use, and caffeine withdrawal headache. These are not life-threatening but have pathophysiological mechanisms.

Sign in to read the full notes

Get access to AI-generated notes, topic timestamps, and more.